JUST-AAV Trademark

Pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; pharmaceutical preparations containing adeno-associated virus (AAV) protein sequences and nucleic acid sequences for use in gene delivery; therapeutic drugs and agents for use in treatment of growth hormone deficiency, lysosomal disease and renal anemia; therapeutic drugs and agents for applications in regenerative medicine; chemotherapeutics; organotherapy preparations; biological preparations for gene therapy for the treatment of genetic diseases or disorders; biological preparations for use in the treatment of gene therapy treatable diseases; gene therapy products, namely, biopharmaceutical preparations primarily composed of adeno-associated virus (AAV) vectors comprising of a transgene or other nucleic acid payload for delivery to a cell or tissue; biological preparations for gene therapy; reagents for medical or veterinary purposes; antibodies for medical or veterinary purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; viral vectors for medical use relating to gene therapy; gene therapy preparations for neurological diseases; pharmaceutical preparations acting on the central nervous system; nucleic acid sequences for medical and veterinary purposes; cells for medical or clinical use; enzymes for medical purposes

Chemicals for use in industry and science; diagnostic reagents for scientific or research use; biological preparations for use in industry and science; chemical reagents, other than for medical or veterinary purpose; biochemical reagents used for non-medical purposes; diagnostic reagents and preparations, except for medical or veterinary use; chemical reagents for use in genetic research, other than for medical or veterinary use; chemicals and biochemical products for use in gene delivery technology, other than for medical or veterinary use; active chemical ingredients for use in the manufacture of pharmaceuticals; biological materials, namely, adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for scientific and research purposes and not for medical and veterinary purposes; biological materials, namely, viral vectors in the nature of genetically modified viruses for scientific and research purposes; adeno-associated virus (AAV) vectors, protein sequences and nucleic acid sequences for use in scientific research and pharmaceutical research; nucleic acid sequences, other than for medical or veterinary purposes

Medical research; chemical research; testing, inspection or research in the field of chemistry; chemical analysis; medical and scientific research, namely, conducting clinical trials for others; testing, inspection or research of pharmaceuticals; gene therapy research; development of gene-based medicines; research and development services relating to medicines; research and development in the field of biotechnology; development of new technology for others in the field of medicine, science, and chemistry; research and development of new products for others; laboratory services for biomanufacturing; scientific research; providing medical and scientific research information in the field of pharmaceuticals; research and development services in the field of platform technologies for genetic delivery of therapies and pharmaceuticals; consultation and research in the field of gene delivery technology; consultation and research in the field of drug delivery technology; research and development of vaccines; quality control for others